Sartorius Stedim Biotech

Life Sciences Tools & Services
DIM.PA
€ 311 (2.1)%
Share price
$ 28 bn
Market Cap
$ 28 bn
Enterprise Value

Carbon footprint

1.3 Ton
GHG emissions per $ 1 mln investment
0.03x the weighted average for S&P 500
FY2021
How is this calculated?
+4.7%
YOY change in GHG emissions
In line with the +4.9% weighted average for S&P 500
FY2021 vs. previous year

Primary Climate Goal

-4.9%
Proj. YOY change in GHG emissions (Scope 1 + 2)
Weaker than the -6.6% weighted average for S&P 500
FY2022
How is this calculated?

Sartorius Stedim Biotech aims to reduce Scope 1 + 2 by 45% by 2030 from a base year 2019


This target has not been verified as science based according to SBTi
Sartorius Stedim Biotech's actual and proj. GHG emissions (Scope 1 + 2) (Kt of CO2e)

GHG emissions and Carbon intensity

Sartorius Stedim Biotech's GHG emissions (location-based) (Kt of CO2e)
Sartorius Stedim Biotech's Carbon intensity (Tons per 1 USDm)

Sartorius Stedim Biotech's carbon footprint

Sartorius Stedim Biotech reported Total CO2e Emissions - Location-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2021 at 37 Kt (+1.7/+4.7% y-o-y). At the sime time, carbon intensity decreased sharply to 11 t (-5 /-31.6% y-o-y).

Sartorius Stedim Biotech reported Scope 3 emissions for the the twelve months ending31 December 2021 at 298

The company is committed to reducing Scope 1 + 2 by 45% by 2030 from a base year 2019, which translates into the estimated reduction of -1.8 Kt per annum over the period of FY2022 - FY2030. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.

Company environmental metrics

Show more...